Influenza, Human Clinical Trial
Official title:
Nudging for Vaccination : Efficacity and Acceptability Among Medical Students
Nudge is a set of methods aimed at helping people adopt a behavior by a gentle prompt,
conscious or not. Classically, Nudges rely on heuristics and cognitive biases. These methods
have been studied for years in social psychology and are receiving renewed attention since
the awarding of the Nobel Prize in economics to Richard Thaler for his work on the
application of Nudge to the economy.
Health professionals are very inadequately vaccinated (25 to 45% of the population). Some
studies have shown that a Nudge based on intent implementation can significantly increase
vaccination coverage. However, few studies evaluate the acceptability of Nudge or its
application to health professionals.
The investigators sought to apply a Nudge based on availability heuristics to health
professionals, in order to evaluate its effectiveness and terms of behavior adoption
(influenza vaccination) and its acceptability.
The investigator's hypothesis is that Nudging is both effective and acceptable and that
people found nudging more acceptable if they have been exposed to a nudge.
The investigators asked residents in general medicine to pass a questionnaire including a
Nudge. This Nudge was the influenza vaccine prescription form accompanied on the back of the
telephone numbers of the occupational health centers of the hospitals where residents were on
probation.
The interns of the group "Nudge" saw at the end of their questionnaire the following
statement: "If you are not vaccinated against the flu so far, you can get the form stapled to
this questionnaire, it will allow you to get the vaccine in pharmacy. On the back you will
also find practical information about immunization services at your place of training. " A
group will receive an implemented Nudge questionnaire, a group will receive a questionnaire
without Nudge and a control group will not be asked. (Phase 1) The 3 groups will receive a
month later a questionnaire evaluating the effectiveness in terms of immunization coverage,
and the acceptability of the Nudge, for oneself and for others. (Phase 2) The control group
will only receive the Phase 2 questionnaire to control the Hawthorne effect.
The difference between the 3 groups will consist exclusively in the exposure of the
participants to:
- A questionnaire on their attitude (opinion) towards vaccination;
- The numbers of the occupational health vaccination centers of their places of training;
- The flu vaccine prescription form, to be signed and stamped by a doctor (also already
freely available on the internet)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Completed |
NCT03275389 -
A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years
|
Phase 1 | |
Completed |
NCT05981846 -
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
|
Phase 2 | |
Completed |
NCT05044195 -
A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age
|
Phase 3 | |
Completed |
NCT02914275 -
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
|
Phase 3 | |
Completed |
NCT04590066 -
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
|
N/A | |
Recruiting |
NCT03778203 -
Development of Childhood Anti-influenza Immunity
|
Phase 4 | |
Completed |
NCT04527614 -
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection
|
N/A | |
Terminated |
NCT03658629 -
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
|
Phase 2 | |
Completed |
NCT05269290 -
Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections
|
Phase 3 | |
Completed |
NCT06385821 -
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
|
Phase 3 | |
Completed |
NCT02998996 -
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02883972 -
Childhood Influenza Immunisation Invitation Trial in Schools
|
N/A | |
Completed |
NCT02984280 -
Specific Respiratory Infections as Triggers of Acute Medical Events
|
N/A | |
Completed |
NCT02867358 -
A Clinical Trial of KT07 Capsule in the U.S.A
|
Phase 2 | |
Completed |
NCT02545543 -
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age
|
Phase 3 | |
Completed |
NCT02621164 -
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents
|
Phase 3 | |
Completed |
NCT02212106 -
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
|
Phase 4 | |
Completed |
NCT02243774 -
Mail Outreach To Increase Vaccination Acceptance Through Engagement
|
N/A | |
Completed |
NCT02344134 -
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects
|
Phase 3 |